at Zacks.com (Jan 12, 2015)
Teva Pharmaceutical (TEVA +0.3%) says the FDA has approved its Abbreviated New Drug Application for the generic version of Shire's (SHPG) Adderall XR capsules for the treatment of ADD. Adderall XR had annual sales, including brand and generic sales, of approximately $2B in the U.S. last year.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Jan 9, 2015)
at CNBC.com (Jan 5, 2015)
at Zacks.com (Dec 31, 2014)
at Nasdaq.com (Dec 31, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs